Lockheed Martin Investment Management CO Gilead Sciences, Inc. Transaction History

Lockheed Martin Investment Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $1.13 Million - $1.32 Million	-17,400 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $903,216 - $1.1 Million	12,400 Added 248.0%	17,400 $0
Q4 2017 Jan 18, 2018	BUY	$71.15 - $83.52 $71,150 - $83,520	1,000 Added 25.0%	5,000 $358,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $288,440 - $341,880	4,000	4,000 $324,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Lockheed Martin Investment Management CO with notifications on news.